Kim Trautman Leaves US FDA's Device Center For Private Sector
This article was originally published in SRA
Executive Summary
Kim Trautman, one of the chief architects of the US Food and Drug Administration's Quality System Regulation and, more recently, the global medical device single audit program (MDSAP) left the agency for the private sector effective Jan. 8.